Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Barbieri

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Nature Communications|January 8, 2024
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
Nature Medicine|August 15, 2017
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4Xiangpeng Dai, Wenjian Gan, Xiaoning Li, et al.
Nature Genetics|June 2, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Nature Genetics|April 4, 2018
The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
JCO Precision Oncology|October 9, 2019
Integrative Molecular Analysis of Patients With Advanced and Metastatic CancerVerena Sailer, Kenneth Wa Eng, Tuo Zhang, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Nature Communications|January 8, 2024
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Daniel N Rodrigues, Pasquale Rescigno, et al.
Nature Medicine|August 15, 2017
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4Xiangpeng Dai, Wenjian Gan, Xiaoning Li, et al.
Nature Genetics|June 2, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Nature Genetics|April 4, 2018
The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Cell|April 30, 2013
Punctuated evolution of prostate cancer genomesSylvan C Baca, Davide Prandi, Michael S Lawrence, et al.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
JCO Precision Oncology|October 9, 2019
Integrative Molecular Analysis of Patients With Advanced and Metastatic CancerVerena Sailer, Kenneth Wa Eng, Tuo Zhang, et al.
Pageof 11